Grand Rounds: Treatment of Migraine in Youths: What’s current, new and beyond the guidelines?

Objectives (Educational Content) :

1. Describe when to integrate CGRP targeted therapies, neuromodulation devices and procedural treatment in pediatric migraine treatment. 2. Identify treatment options in youths with prolonged migraine attacks. 3. Review how evidence-based cognitive behavioral strategies for pain can help youths with migraine.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.

Identified Gap:

To provide up-to-date knowledge, practical insights and actionable strategies for management of migraine in youths who do not respond to typical migraine treatment.

Estimated Time to Complete the Educational Activity:

1 hour(s)

Expiration Date for CE/CME Credit:

05-08-2026

Method of Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.

Disclosure:

The following presenters have indicated that there are no financial relationship with any ineligible companies: Danielle Freeman, APRN-CNP Sarah Love, PsyD The following planning committee member has indicated that a financial relationship with an ineligible company: Merk M. Christina C Victorio, MD. FAAN, FAHS All relationships have been mitigated. The remaining planning committee/CME committee members have indicated that they have no financial relationships with any ineligible companies.

Accreditation Statement:

Akron Children’s Hospital is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

Akron Children’s Hospital designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Bibliography:

1. Brain, Volume 137, Issue 1, January 2014, Pages 232–241, https://doi.org/10.1093/brain/awt320

2. Oskoui, M., Pringsheim, T., Billinghurst, L., Potrebic, S., Gersz, E. M., Gloss, D., ... & Hershey, A. D. (2019). Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 93(11), 500-509.

3. Powers, S. W., Kashikar-Zuck, S. M., Allen, J. R., LeCates, S. L., Slater, S. K., Zafar, M., ... & Hershey, A. D. (2013). Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. Jama, 310(24), 2622-2630.